Streptococcus pyogenes antigens
AssigneeID Biomedical Corporation
InventorsDenis Martin, Josee Hamel, Bernard Brodeur, Stephane Rioux, Martine Boyer
Life of this patent
Estimating the term…
Abstract
The present invention relates to antigens, more particularly an antigen of Streptococcus pygenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.
Claims47
An isolated polynucleotide encoding a polypeptide having at least 70% identity to a second polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polynucleotide encoding a polypeptide having at least 70% identity to a second polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
An isolated polynucleotide encoding a polypeptide capable of generating antibodies having binding specificity for a polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polynucleotide encoding a polypeptide capable of generating antibodies having binding specificity for a polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
A polynucleotide which hybridizes under stringent conditions to a second polynucleotide having a sequence chosen from:
- SEQ ID NOs:
- 1, 3, 5, 7, 9, 11, 13, 15, 19.
A polynucleotide which hybridizes under stringent conditions to a second polynucleotide having a sequence chosen from:
- SEQ ID NOs:
- 1, 3, 5, 7, 9, 11, 13, 15, 19.
An isolated polynucleotide having a sequence comprising SEQ ID NO:19.
An isolated polypeptide having at least 70% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polypeptide having at least 95% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polypeptide having at least 70% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
An isolated polypeptide having at least 95% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
An isolated polypeptide capable of generating antibodies having binding specificity for a second polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polypeptide capable of generating antibodies having binding specificity for a second polypeptide having a sequence chosen from:
- SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
An isolated polypeptide having an amino acid sequence chosen from SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16, 20 or fragments, analogues or derivatives thereof.
An isolated polypeptide having an amino acid sequence chosen from SEQ ID NOs:
- 2, 4, 6, 8, 10, 12, 14, 16 or 20.
Dependencies are inferred from the claim text.